About Centivax
Centivax is a Healthcare company based in San Francisco (United States) founded in 2019. Drug discovery services are provided to pharmaceutical and biotech clients. Centivax has raised $92 million across 5 funding rounds from investors including NIH, US Navy and Gates Foundation. Centivax offers products and services including Broad-Spectrum Vaccine. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Cell and Molecular Biology. Its competitors include Medeloop, Hyku Biosciences and Biolexis Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Centivax was established in 2019 and is based in San Francisco, United States. Drug discovery services are offered by the company within the biotechnology sector, focusing on early-stage research and development for therapeutics. Operations include target identification, compound screening, and preclinical validation, conducted by a team leveraging the regions scientific resources. The domain centivax.com is utilized for online presence and client engagement.
- Headquarters San Francisco, United States
- SectorsHealthcare
- Website centivax.com
- Social LinkedIn X Instagram YouTube
- Total Equity Funding$92M (USD)
in 5 rounds
- Latest Funding Round$37M (USD), Series A
Mar 2026
- InvestorsNIH
& 14 more
Products & Services of Centivax
Centivax offers a comprehensive portfolio of products and services, including Broad-Spectrum Vaccine.
Pre-clinical vaccine for preventing all influenza strains in animals.
Apps and channels of Centivax
its YouTube channel Centivax has 1.38K subscribers and 2 videos.
Videos from Centivax
The most watched videos on Centivax's YouTube channel, Centivax (1.38K subscribers). Click a video to play it here.
More on Centivax.
Funding Insights of Centivax
Centivax has successfully raised a total of $92M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $37 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $92M
- Total Rounds 5
- Last Round Series A — $37M
- First Round $1.99M
(Aug 2019)
- Investors Count 15
All 5 funding rounds of Centivax with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2026 | $37M | Series A | – | Structure Fund | |
| Jul 2025 | $24M | Grant | – | – | |
| Jul 2025 | $45M | Series A | – | Future Ventures | |
| Nov 2022 | $10M | Seed | – | NFX, Global Health Investment | – |
| Aug 2019 | $1.99M | Grant | – | – |
15 investors in total: 13 institutional and 2 angel.
Investors in Centivax
Centivax has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include NIH, US Navy and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm offering funding and tools for startups in technology and investment sectors. | nfx.com | |||
Future Ventures is focused on early-stage venture capital investments. | future.ventures | Los Altos, United States | ||
Early-stage life sciences and tech focused VC firm investing primarily in the US | boldcapitalpartners.com | Santa Monica, United States | ||
Venture capital investments are focused on health technology breakthroughs. | kcpventures.com | Boston, United States | ||
Healthcare investments are targeted by this private equity firm. | 2017 | cepi.net | Oslo, Norway | |
| structurefund.com | ||||
Global health technologies are supported through strategic investments. | ghicfunds.org | |||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for Centivax
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Centivax
27 people are tracked at Centivax (7 in leadership, 14 in board & advisors, 6 in team).
| Name | Role | Group |
|---|---|---|
Nicholas Bayless | CTO | Leadership |
Jacob Glanville | CEO | Leadership |
David Tsao | COO | Leadership |
Dave Gangemi | Chief Government Relations Officer | Leadership |
Sawsan Youssef | Chief Science Officer | Leadership |
Stephanie Wisner | Chief Business Officer | Leadership |
Rishi Bedi | Director, Machine Learning & IO | Leadership |
Ted Ross | Advisor | Board & advisors |
William Finlay | Advisor | Board & advisors |
Pam Garzone | Advisor | Board & advisors |
Peter Moesta | Advisor | Board & advisors |
Matthew Frank | Advisor | Board & advisors |
Erwin Calgua | Advisor | Board & advisors |
John Cumbers | Advisor | Board & advisors |
Tammie Meek | Advisor | Board & advisors |
Lawrence Steinman | Advisor | Board & advisors |
John Desjarlais | Advisor | Board & advisors |
Peter Kwong | Advisor | Board & advisors |
Jotham Stein | Advisor | Board & advisors |
Phil Krause | Advisor | Board & advisors |
7 more people are available in the full profile.
Complete people profiles for Centivax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Centivax
3 dated milestones of Centivax across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Centivax is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series A, of $37.0M.
Competitors of Centivax
Centivax has 3 listed competitors in our database, 3 of them funded. They include Medeloop, Hyku Biosciences and Biolexis Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medeloop.ai | 2021 | Palo Alto, United States | $23.5M | Drug discovery services are offered by Medeloop as a CRO. | ||
| hykubiosciences.com | 2023 | Lexington, United States | $56M | Covalent medicines platform is advanced for drug discovery targeting proteins. | ||
| biolexistx.com | 2021 | Salt Lake, United States | $12.5M | CRO focused on drug discovery of small molecule therapeutics |
Detailed competitors of Centivax
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Centivax
The website of Centivax (centivax.com) receives about 4.3K visits a month.
- Monthly visits4.3K
▼ 2.9% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Centivax (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Centivax
Complete news archive for Centivax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centivax
Centivax was founded in 2019.
Centivax is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Centivax is a funded company, having raised a total of $92M across 5 funding rounds to date. The company's 1st funding round was a Grant of $1.99M, raised on Aug 2019.
Centivax was established in 2019 and is based in San Francisco, United States. Drug discovery services are offered by the company within the biotechnology sector, focusing on early-stage research and development for therapeutics. Operations include target identification, compound screening, and preclinical validation, conducted by a team leveraging the regions scientific resources. The domain centivax.com is utilized for online presence and client engagement.
Centivax's top competitors include Medeloop, Hyku Biosciences and Biolexis Therapeutics.
Centivax offers Broad-Spectrum Vaccine.
Centivax has 15 investors. Key investors include NIH, US Navy, Gates Foundation, HHS, and CEPI.